Since new evidence supports that the clinical application of wortmannin may be revived through nanoparticle drug delivery [8], wortmannin was used in this study to investigate the effects of PI3K/AKT blockade on in vivo metastasis of human ESCC cells in mice. This evidence concerns the gene AKT1 and esophageal squamous cell carcinoma.